These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 19373300

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art.
    Rapaport MH.
    J Clin Psychiatry; 2007; 68 Suppl 8():42-6. PubMed ID: 17640157
    [Abstract] [Full Text] [Related]

  • 26. Antidepressive treatment with monoamine oxidase inhibitors and the occurrence of intraoperative hemodynamic events: a retrospective observational cohort study.
    van Haelst IM, van Klei WA, Doodeman HJ, Kalkman CJ, Egberts TC, MAOI Study Group.
    J Clin Psychiatry; 2012 Aug; 73(8):1103-9. PubMed ID: 22938842
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics of monoamine oxidase inhibitors.
    Mallinger AG, Smith E.
    Psychopharmacol Bull; 1991 Aug; 27(4):493-502. PubMed ID: 1813896
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. What is the bottom line for dietary guidelines when taking monoamine oxidase inhibitors?
    Marcason W.
    J Am Diet Assoc; 2005 Jan; 105(1):163. PubMed ID: 15635366
    [No Abstract] [Full Text] [Related]

  • 32. 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors.
    Fallon B, Foote B, Walsh BT, Roose SP.
    J Clin Psychiatry; 1988 Apr; 49(4):163-5. PubMed ID: 3281932
    [Abstract] [Full Text] [Related]

  • 33. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM, Masica DN, Heiligenstein JH, Wheadon DE, Zerbe RL.
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [Abstract] [Full Text] [Related]

  • 34. Interaction between the irreversible MAOIs and certain foods.
    Beavis D.
    Aust Fam Physician; 1999 Jul; 28(7):650, 652. PubMed ID: 10431417
    [No Abstract] [Full Text] [Related]

  • 35. Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants?
    Park SH, Wackernah RC, Stimmel GL.
    J Pharm Pract; 2014 Feb; 27(1):71-8. PubMed ID: 24153222
    [Abstract] [Full Text] [Related]

  • 36. Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.
    Baker GB, Coutts RT, McKenna KF, Sherry-McKenna RL.
    J Psychiatry Neurosci; 1992 Nov; 17(5):206-14. PubMed ID: 1362653
    [Abstract] [Full Text] [Related]

  • 37. Reversible Cerebral Vasoconstriction Syndrome and Monoamine Oxidase Inhibitors.
    Durmuş B, Osse RJ, Emmer B, van Kooten F.
    Prim Care Companion CNS Disord; 2016 Dec 01; 18(6):. PubMed ID: 27922229
    [No Abstract] [Full Text] [Related]

  • 38. Toxic interaction of venlafaxine and isocarboxazide.
    Klysner R, Larsen JK, Sørensen P, Hyllested M, Pedersen BD.
    Lancet; 1995 Nov 11; 346(8985):1298-9. PubMed ID: 7475741
    [No Abstract] [Full Text] [Related]

  • 39. Tranylcypromine discontinuation symptoms and withdrawal delirium.
    Freudenmann RW, Baumgarten E, Hawlik AE, Schönfeldt-Lecuona C, Gahr M.
    J Clin Psychopharmacol; 2013 Aug 11; 33(4):574-6. PubMed ID: 23771195
    [No Abstract] [Full Text] [Related]

  • 40. Moclobemide and the risk of serotonin toxicity (or serotonin syndrome).
    Gillman K.
    CNS Drug Rev; 2004 Aug 11; 10(1):83-5; author reply 86-8. PubMed ID: 15046013
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.